OTLK · Outlook Therapeutics, Inc. · Off Exchange
$0.59
+0.02 (+3.13%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because our cash and cash equivalents, together with $51.1 million of net proceeds from our August 2026 Offering, will not be adequate to fund our currently planned operations through at least the 12 months from the date of this Quarterly Report, there is substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Aug 18, 2026
Market Cap
$155.68M
Shares
243.45M
Volume · Oct 2
5.62M
Avg daily vol (3M)
13.63M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-08-24 | 3,315,615 | 30,225,359 | 33,540,974 | 63.1% |
| 2026-08-17 | 9,161,100 | 118,898,855 | 128,059,955 | 78.7% |
| 2026-08-10 | 13,477,891 | 141,863,210 | 155,341,101 | 73.5% |
| 2026-08-03 | 2,413,686 | 21,549,320 | 23,963,006 | 70.0% |
| 2026-07-27 | 6,964,611 | 82,363,308 | 89,327,919 | 73.3% |
| 2026-07-20 | 5,963,969 | 39,646,431 | 45,610,400 | 54.6% |
| 2026-07-13 | 3,417,447 | 26,276,802 | 29,694,249 | 57.7% |
| 2026-07-06 | 3,365,143 | 22,087,911 | 25,453,054 | 60.0% |
| 2026-06-29 | 1,541,729 | 16,563,822 | 18,105,551 | 65.4% |
| 2026-06-22 | 4,151,853 | 31,882,867 | 36,034,720 | 61.9% |
| 2026-06-15 | 6,224,901 | 65,695,400 | 71,920,301 | 64.6% |
| 2026-06-08 | 7,892,292 | 76,509,712 | 84,402,004 | 69.7% |
| 2026-06-01 | 5,384,750 | 60,238,135 | 65,622,885 | 67.5% |
| 2026-05-25 | 19,032,127 | 338,520,328 | 357,552,455 | 62.8% |
| 2026-05-18 | 1,212,739 | 26,196,186 | 27,408,925 | 65.0% |
| 2026-05-11 | 489,514 | 9,881,041 | 10,370,555 | 68.3% |
| 2026-05-04 | 1,276,149 | 17,633,152 | 18,909,301 | 69.3% |
| 2026-04-27 | 774,860 | 13,299,045 | 14,073,905 | 69.2% |
| 2026-04-20 | 1,420,563 | 22,258,737 | 23,679,300 | 65.0% |
| 2026-04-13 | 726,158 | 8,947,372 | 9,673,530 | 66.7% |
| 2026-04-06 | 2,037,856 | 20,546,393 | 22,584,249 | 62.9% |
| 2026-03-30 | 625,674 | 6,054,889 | 6,680,563 | 64.3% |
| 2026-03-23 | 2,724,712 | 21,539,177 | 24,263,889 | 62.2% |
| 2026-03-16 | 870,635 | 4,703,682 | 5,574,317 | 50.7% |
| 2026-03-09 | 301,714 | 2,852,012 | 3,153,726 | 53.5% |
| 2026-03-02 | 284,861 | 2,659,390 | 2,944,251 | 63.2% |
| 2026-02-23 | 153,201 | 2,343,639 | 2,496,840 | 60.9% |
| 2026-02-16 | 190,352 | 3,594,849 | 3,785,201 | 65.2% |
| 2026-02-09 | 270,618 | 6,074,105 | 6,344,723 | 63.5% |
| 2026-02-02 | 329,550 | 3,169,701 | 3,499,251 | 58.4% |
| 2026-01-26 | 400,990 | 7,611,879 | 8,012,869 | 68.2% |
| 2026-01-19 | 352,266 | 5,261,320 | 5,613,586 | 64.3% |
| 2026-01-12 | 654,359 | 9,768,121 | 10,422,480 | 70.5% |
| 2026-01-05 | 4,540,983 | 67,571,162 | 72,112,145 | 75.8% |
| 2025-12-29 | 7,124,506 | 83,623,537 | 90,748,043 | 70.1% |
| 2025-12-22 | 2,173,580 | 9,379,464 | 11,553,044 | 65.5% |
| 2025-12-15 | 2,107,463 | 11,965,744 | 14,073,207 | 61.6% |
| 2025-12-08 | 567,119 | 4,886,850 | 5,453,969 | 58.8% |
| 2025-12-01 | 741,909 | 6,756,878 | 7,498,787 | 60.4% |
| 2025-11-24 | 1,630,408 | 6,981,267 | 8,611,675 | 62.3% |
| 2025-11-17 | 2,404,397 | 13,392,997 | 15,797,394 | 62.0% |
| 2025-11-10 | 5,153,891 | 32,447,923 | 37,601,814 | 65.4% |
| 2025-11-03 | 278,253 | 1,762,945 | 2,041,198 | 64.7% |
| 2025-10-27 | 241,197 | 1,945,886 | 2,187,083 | 63.9% |
| 2025-10-20 | 312,957 | 3,465,317 | 3,778,274 | 62.2% |
| 2025-10-13 | 1,008,346 | 5,667,889 | 6,676,235 | 57.3% |
| 2025-10-06 | 1,013,859 | 5,809,218 | 6,823,077 | 59.6% |
Showing 1–47 of 47 weeks
Key facts
CIK
1649989
CUSIP
69012T305
13F (30d)
11 filings
3 filers
Visit website
Investor relations